Vertex CEO on Innovation: The Challenge is Avoiding Complacency

Vertex’s CEO talks about the importance of investing in R&D — and the three pitfalls for companies that have attained success in the marketplace, including complacency.

By Scott Kirsner · August 27, 2017 · 1 min read

Jeffrey Leiden is CEO of Vertex Pharmaceuticals, a $1.7 billion maker of drugs for cystic fibrosis. We spoke with him at Vertex’s Boston headquarters about how he oversees the company’s R&D organization.Early in our conversation with Leiden, he recounted some of the challenges…

More like this

XTuit CEO: ‘Connect Scientists with the Outside World’

Corporate Innovators Talk Cost-Cutting and the Need to Reinvest in Innovation

Six Tips from Innovation VP at Partners HealthCare

COMMENTS